Full-Time

User Researcher and Human Factors Engineer

Updated on 5/7/2025

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing technology provider

Compensation Overview

$140k - $190k/yr

+ Cash Bonus + Stock Options

Senior

San Francisco, CA, USA

Hybrid position; specific in-office days not mentioned.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
SCRUM
Data Analysis
Requirements
  • Outstanding communication skills, both written and oral.
  • Proven ability to handle ambiguity, work collaboratively with internal and partner contacts, and influence cross-functional teams.
  • Strong technical aptitude.
  • Direct experience with scrum methodologies for product development and delivery.
  • Highly productive with exceptional organizational capacity.
  • Demonstrated passion for problem solving.
  • Proficiency in user research tools.
  • Experience with data analysis tools.
  • Bachelor’s degree or higher preferably in Human Factors Engineering, Cognitive Psychology, Human-Computer Interaction, or a related field.
  • 5+ years of experience UX research and human factors engineering, preferably in medical devices or healthcare.
  • 3+ years in the SaMD industry.
  • Demonstrated experience with FDA human factors guidance.
  • Strong portfolio showcasing research methods, analysis, and impact on product development.
  • Experience with both formative and summative usability testing.
Responsibilities
  • Conduct research to gain insights into the needs, behaviors, and preferences of both healthcare professionals and patients who will use the software as a medical device (SaMD).
  • Design, conduct, and document comprehensive user research studies, formative, and summative testing, to inform user personas, product development, and validate usability.
  • Work closely with designers, developers, product managers, and other stakeholders to ensure that user needs are incorporated into the design and development process.
  • Identify potential usability issues, design problems, and opportunities for improvement in the software's user interface and overall user experience.
  • Design and implement various research methods, such as interviews, surveys, usability testing, and field studies, to gather data and insights.
  • Analyze the data to identify key findings and provide recommendations to the design and development team.
  • Understand the intended users of the device, their skills, and their limitations in order to inform the design an effective interface.
  • Inform the device design to prevent safety errors and to allow for easy recovery from errors.
  • Provide adequate training and documentation to ensure safe and effective use of the device.
  • Ensure that the software is safe, effective, and meets regulatory requirements.

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning. The goal is to improve cardiovascular care by making it safer and more efficient.

Company Size

501-1,000

Company Stage

Debt Financing

Total Funding

$1B

Headquarters

Redwood City, California

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • HeartFlow's technology aligns with the growing trend of AI adoption in healthcare.
  • The global non-invasive cardiac imaging market is projected to grow significantly, benefiting HeartFlow.
  • Updated AHA guidelines emphasize non-invasive testing, increasing demand for HeartFlow's FFRCT Analysis.

What critics are saying

  • Emerging AI-driven cardiovascular tools could threaten HeartFlow's market share.
  • HeartFlow's reliance on continuous funding rounds indicates potential financial instability.
  • New regulatory requirements for AI in healthcare could necessitate costly adjustments for HeartFlow.

What makes HeartFlow unique

  • HeartFlow offers a unique AI-driven non-invasive cardiac test for coronary artery visualization.
  • The company's technology integrates over two decades of scientific evidence with AI advancements.
  • HeartFlow is the only provider offering both anatomical and physiological coronary artery visualization.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-2%
Intelligence360
Apr 22nd, 2025
HeartFlow Raises $50M in Debt Financing

HeartFlow has filed a notice for an exempt offering of securities to raise $50 million in new debt financing. This filing with the U.S. Securities and Exchange Commission is required under federal securities law for companies selling securities without registration under the Securities Act of 1933, specifically under Rule 504 or 506 of Regulation D or Section 4(a)(5). The notice must be filed within 15 days after the first sale of securities in the offering.

Benzinga
Mar 26th, 2025
Heartflow Secures $98M in Funding

Heartflow, Inc. announced a $98 million convertible notes financing led by its parent company, Heartflow Holding, Inc. New and existing investors, including Fidelity Management, Janus Henderson, and Bain Capital, participated. The funds will support R&D to advance Heartflow's AI-driven coronary care platform. Heartflow's technology, recognized for innovation, aims to improve CAD diagnosis and management. The platform has been used for over 400,000 patients globally.

National Law Review
Mar 26th, 2025
Heartflow Closes $98 Million Convertible Notes Financing

Heartflow was recently named one of Fast Company's Most Innovative Companies in Medical Devices for 2025 and won the Innovation in Cardiac Imaging award at the Global Cardiovascular Awards 2025.

Hit Consultant
Jan 22nd, 2025
Heartflow And Boone Heart Institute Launch Gamefilm Registry To Study Heart Health In Retired Nfl Players

HeartFlow and Boone Heart Institute Launch GAMEFILM Registry to Study Heart Health in Retired NFL Players. by Fred Pennic 01/22/2025 Leave a Comment. What You Should Know: – HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry. – GAMEFILM Registry will utilize advanced imaging and AI technology to assess and better understand coronary artery disease (CAD) risk in retired National Football League (NFL) players.Understanding the Unique Cardiovascular Risks of Retired NFL PlayersCardiovascular disease remains the leading cause of death globally. Despite advancements in diagnostics, many heart attacks and strokes occur in individuals without prior symptoms. Early identification of high-risk individuals is critical for effective prevention and treatment. Retired NFL players often face unique cardiovascular health challenges due to the intense physical demands of their careers

GlobeNewswire
Oct 18th, 2024
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease

HeartFlow announces new Category I CPT code from the American Medical Association for ai-enabled Plaque Analysis to assess risk for coronary artery disease.